venture-med.com
Oncologie Closes an $80M Series B Financing - Venture-Med: Investing in Healthcare Innovation
Oncologie, an innovative biopharmaceutical company using proprietary biomarkers to drive clinical development of next-generation oncology therapeutics, announced today that it has closed an $80M Series B financing.